After-Hours Buzz: Adobe, La-Z-Boy, Teva Pharmaceuticals & More
Merck & Co Inc
featured
The "Fast Money" traders share their final trades of the day and what they're watching in the week ahead.
» Read More
More
-
Baxter International Inc. rose$. 11 or. 2 percent, to $70.84. Bristol-Myers Squibb Co. rose$. 28 or. 6 percent, to $46.72. Hospira rose$. 10 or. 3 percent, to $36.52.
-
Baxter International Inc. rose$. 39 or. 6 percent, to $70.99. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $46.95. Hospira rose$. 36 or 1.0 percent, to $36.60.
-
NEW YORK-- Shares of Codexis Inc. jumped Friday after the company said it reached an important milestone in development of detergent alcohols made from biomass. THE SPARK: Codexis and its partner Chemtex said they have scaled up production of CodeXol detergent alcohols.
-
Baxter International Inc. rose$. 08 or. 1 percent, to $70.83. Bristol-Myers Squibb Co. fell$. 23 or. 5 percent, to $46.94. Hospira fell$. 12 or. 3 percent, to $36.34.
-
June 13- Eli Lilly and Co. said on Thursday it halted a mid-stage study of an experimental Alzheimer's disease treatment due to potential liver toxicity, the latest setback in the quest to find a treatment that can slow or cure the memory-robbing condition.
-
Baxter International Inc. fell$. 01 or percent, to $69.74. Bristol-Myers Squibb Co. fell$. 09 or. 2 percent, to $46.48. Hospira fell$. 05 or. 1 percent, to $35.20.
-
Baxter International Inc. rose$. 15 or. 2 percent, to $69.92. Bristol-Myers Squibb Co. fell$. 17 or. 4 percent, to $47.12. Hospira fell$. 61 or 1.7 percent, to $35.47.
-
Baxter International Inc. rose$. 70 or 1.0 percent, to $70.22. Bristol-Myers Squibb Co. rose$. 23 or. 5 percent, to $47.23. Hospira rose$. 62 or 1.8 percent, to $35.65.
-
Baxter International Inc. fell$. 04 or. 1 percent, to $68.80. Bristol-Myers Squibb Co. rose$. 58 or 1.3 percent, to $46.75. Hospira rose$. 27 or. 8 percent, to $34.76.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. American International Group fell. 7 percent to $43.80 with 15,422,900 shares traded. Bank of America Corp. fell 2.0 percent to $13.08 with 95,376,900 shares traded.
-
Baxter International Inc. fell$. 23 or. 3 percent, to $69.06. Bristol-Myers Squibb Co. fell $1.01 or 2.2 percent, to $45.82. Hospira rose$. 06 or. 2 percent, to $34.51.
-
They included drugs from Bristol-Myers Squibb and Merck& Co that shrank tumors in patients with advanced melanoma and lung cancer. Citigroup analysts expect such "immunotherapies" to cost around $110,000 in the United States for a year's worth of treatment and $80,000 in the rest of the world, generating sales of $35 billion a year in the next 10 years.
-
TOKYO, June 4- U.S. oil edged lower on Tuesday but held above $93 per barrel, as worries about slack demand weighed on prices after a late rebound the previous day on a slump in the dollar. *NYMEX crude for July delivery was down 27 cents at $93.18 a barrel by 2344 GMT, after settling up $1.48 at $93.45 on Monday.
-
NEW YORK, June 3- U.S. stocks rose on Monday, helped by weaker-than-expected factory activity that supported views the Federal Reserve will keep economic stimulus in place, while gains in Merck& Co lifted drug companies.
-
NEW YORK, June 3- U.S. stocks rose on Monday as weaker-than-expected factory activity last month supported views that the Federal Reserve will need to keep economic stimulus in place, while gains in Merck& Co's lifted drug companies. Intel Corp helped the Nasdaq turn positive in the final hour of trading, rising 3.9 percent to $25.23.
-
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
-
NEW YORK, June 3- Stocks and the U.S. dollar struggled on Monday in a seesaw session after data showed U.S. manufacturing activity contracted for the first time in six months, raising concerns about the health of the U.S. recovery. The Institute for Supply Management reported that its gauge for new orders slipped and said there was less demand for exports.
-
NEW YORK, June 3- The S&P 500 index was little changed on Monday as weaker-than-expected factory activity last month fed worries the economic recovery was struggling, while gains in Merck& Co's shares lifted the Dow and other drug companies.
-
NEW YORK, June 3- U.S. stocks were mostly lower in choppy trade on Monday as the latest data on manufacturing continued to paint a mixed picture on the strength of the economy. The S&P 500 fluctuated between losses and gains but the Dow managed to post a slight gain, boosted by a 5.3 percent jump in Merck& Co Inc..
Most Popular Video
The world's second-wealthiest man explains to CNBC why workers in Europe and other parts of the developed world are at the "best" part of their career after they reach their 60s.
Tuesday, 18 Jun 2013 | 10:00 AM ETViolent protests broke out in eight Brazilian cities last night, with the worst violence occurring in Rio de Janeiro. Thousands of protesters threw Molotov cocktails and anything else they could find. The protests began over a 10-cent increase in bus and subway fares.
Tuesday, 18 Jun 2013 | 11:05 AM ETFBI Deputy Director Sean Joyce describes how NSA surveillance helped to detect and thwart a plot to bomb the NYSE.